---
title: ' NR 566 Week 7 Presentation'
description: ' NR 566 Week 7 Presentation'
date: 2024-08-11T21:00:00.000Z
---

### Presentation: Management of Psychiatric Conditions in Primary Care - Attention-Deficit/Hyperactivity Disorder (ADHD)

Presented by: Dharmistha Patel
Course: NR 566 - Advanced Pharmacology for Primary Care
Instructor: Dr. Landry
Institution: Chamberlain College of Nursing
Date: \[Insert Date]

***

### Slide 1: Title Slide

* Title: Management of Psychiatric Conditions in Primary Care: ADHD
* Presented by: Dharmistha Patel
* Course: NR 566 - Advanced Pharmacology for Primary Care
* Institution: Chamberlain College of Nursing

***

### Slide 2: Introduction

* Overview of ADHD:
  * A neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity.
  * Prevalence in both children and adults, often persisting into adulthood.
  * Impact on academic performance, social interactions, and overall quality of life.

***

### Slide 3: Patient Scenario

* Patient Profile:
  * Name: David S.
  * Age: 20 years old
  * Occupation: Third-year college student
  * Referral Reason: Referred due to recent anger outbursts and academic underachievement.
* Chief Complaints:
  * Difficulty concentrating in class, wandering mind, easy frustration.
* Social History:
  * Smokes cigarettes, daily marijuana use, increasing alcohol consumption.

***

### Slide 4: Medical and Family History

* Medical History:
  * Diagnosed with ADHD in 2020.
  * History of anxiety and seasonal allergies.
* Family Medical History:
  * Father: Hypertension
  * Mother: ADHD
* Current Medications:
  * Adderall 5 mg once daily
  * Multivitamin

***

### Slide 5: Treatment Plan - Therapy and Counseling

* Behavior Therapy/Psychological Counseling:
  * Strategies to manage behavior and improve coping skills.
* Cognitive Behavioral Therapy (CBT):
  * Address dysfunctional thinking and behaviors.
* Support Groups:
  * Peer support and shared experiences.
* Family Therapy/Counseling:
  * Involvement of family in the treatment process.

***

### Slide 6: Treatment Plan - Medication Management

* Current Prescription:
  * Increase Adderall dose from 5 mg once a day to 5 mg twice a day.
* Patient Education:
  * Discuss the new dosing schedule and potential side effects.
  * Emphasize the importance of adherence to medication.

***

### Slide 7: Substance Use and Mental Health

* Addressing Substance Use:
  * Discuss the impact of marijuana and alcohol on ADHD and overall mental health.
  * Provide resources and support for reducing substance dependence.

***

### Slide 8: State and Federal Regulations

* State of Practice: Illinois
  * Review scope of practice for FNPs regarding mental health management.
  * Ensure compliance with state and federal regulations on controlled substances.

***

### Slide 9: Follow-Up and Monitoring

* Regular Follow-Up:
  * Monitor the effectiveness of the increased Adderall dose.
  * Assess progress in reducing substance use.
* Continued Support:
  * Ongoing counseling and family support.
  * Adjust treatment plan as needed based on patient response.

***

### Slide 10: Conclusion

* Key Takeaways:
  * Comprehensive ADHD management includes medication, therapy, and patient education.
  * Addressing substance use is critical to the success of ADHD treatment.
  * Regular monitoring and adherence to regulations ensure effective care.

References:

* Centers for Disease Control and Prevention (CDC). (2018). Behavioral therapy for ADHD. Retrieved from [https://www.cdc.gov/ncbddd/adhd/behavior-therapy.html](https://www.cdc.gov/ncbddd/adhd/behavior-therapy.html)
